MELVILLE, N.Y., June 6 /PRNewswire/ -- Specialty pharmaceutical manufacturer Fougera, a division of ALTANA Inc, today announced it is first- to-market with generic Metronidazole Topical Gel USP 0.75% (Rx). The patent on the branded product by Galderma, which generates approximately $75 million in sales annually, expires today.
(Photo: http://www.newscom.com/cgi-bin/prnh/20060606/NYTU002 )
With Metronidazole Topical Gel, Fougera becomes the first company to offer a complete range of generic Metronidazole products in all three presentations, including Cream, Lotion and now, Gel. All Fougera Metronidazole products are offered at the established strength of 0.75%, facilitating an easy transition to the more cost-effective generic product for existing patients, and providing an attractive option for new patients.
Metronidazole Topical Gel USP 0.75% (Rx) is indicated for the treatment of rosacea (see product package insert for full prescribing information). The Fougera gel product is available in 45g tubes (NDC # 0168-0275-45).
The approval of Metronidazole Topical Gel USP 0.75% (Rx) continues Fougera’s record of achieving more topical FDA approvals than any other generic pharmaceuticals company in the past six years. This continuing stream of new products benefits both health care providers and patients seeking multi-source alternatives and reduced costs.
David Klaum, Senior Vice President, Commercial Business Operations, stated, “First-to-market Metronidazole Gel, an important addition to Fougera’s line of facial products, joins our Metronidazole Cream and Metronidazole Lotion to give health care providers the ability to choose the topical formulation that’s right for their patients. At Fougera, our focus is always on providing our customers with the quality generic products they demand, in the formulations that suit their individual needs.”
Fougera is a specialty pharmaceutical manufacturer of topical steroids, antibiotics and antifungal products, as well as ophthalmics. For more information on Fougera’s complete line of topicals, or any other quality Fougera product, please call Fougera Customer Service at (800) 645-9833. Or visit the company online at http://www.fougera.com.
Fougera is a leading manufacturer and distributor of a wide range of multi-source topical and ophthalmic pharmaceuticals, in both prescription and over-the-counter dosage forms.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20060606/NYTU002PRN Photo Desk, photodesk@prnewswire.comFougera
CONTACT: Julie Gross Gelfand of HLD\Blankman Public Relations,+1-516-536-6822, +1-212-896-3926, or jgelfand@hldbnow.com, for Fougera
Web site: http://www.fougera.com/
